MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1039/d5ra07254a

Медицинская библиотека · RSC advances · 2025

New coumarin-chalcone-triazole hybrids as promising anti-diabetic agents: from molecular design to in vivo validation.

Peytam Fariba, Norouzbahari Maryam, Akbari Mahsa, Gülcan Hayrettin Ozan, Moradi Mahfam, Mojtabavi Somayeh, Faramarzi Mohammad Ali, Ghasemi Fahimeh, Torabi Mohammadreza, Tehrani Maliheh Barazandeh, Sheibani Vahid, Firoozpour Loghman, Foroumadi Alireza

СтатьяПеревод пока не подготовлен

Аннотация

A series of coumarin-chalcone-1,2,3-triazoles were designed and synthesized as potential antidiabetic agents targeting α-glucosidase. Among them, compound 20q exhibited exceptional inhibitory potency (IC50 = 0.50 ± 0.04 µM), significantly outperforming acarbose (IC50 = 750.08 ± 1.52 µM). Kinetic analyses confirmed a competitive inhibition mechanism, and computational studies-including deep-learning prediction, molecular docking, and molecular dynamics simulations-revealed strong and stable interactions of 20q with the enzyme active site, supporting its efficacy. This compound showed no cytotoxicity and α-amylase inhibition even at high concentrations, indicating its favorable safety profile with high selectivity. CD and fluorescence studies demonstrated that its binding induced a more ordered enzyme conformation (increased α-helix, reduced β-sheet/coil) through static, electrostatic interactions. In vivo assessments with compound 20q showed no acute toxicity at doses up to 1000 mg kg-1 and a dose-dependent antihyperglycemic effect, restoring fasting blood glucose and HbA1c levels to near-normal values, and improving liver and pancreas histopathology at 8 mg kg-1 BW, outperforming acarbose at a comparable dose. These comprehensive findings identify compound 20q as a highly potent, selective, and safe α-glucosidase inhibitor with significant potential for further development as an antidiabetic agent.

Для цитирования: Peytam Fariba, Norouzbahari Maryam, Akbari Mahsa, Gülcan Hayrettin Ozan, Moradi Mahfam, Mojtabavi Somayeh, Faramarzi Mohammad Ali, Ghasemi Fahimeh, Torabi Mohammadreza, Tehrani Maliheh Barazandeh, Sheibani Vahid, Firoozpour Loghman, Foroumadi Alireza. New coumarin-chalcone-triazole hybrids as promising anti-diabetic agents: from molecular design to in vivo validation.. RSC advances. 2025. DOI: 10.1039/d5ra07254a.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.